ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 34 filers reported holding ETON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,203,060 | +21.6% | 528,310 | +1.7% | 0.63% | +23.8% |
| Q2 2023 | $1,812,202 | -9.0% | 519,251 | +0.4% | 0.51% | -12.5% |
| Q1 2023 | $1,991,617 | +66154.7% | 517,301 | -6.7% | 0.58% | +8257.1% |
| Q4 2022 | $3,006 | -99.9% | 554,201 | +17.3% | 0.01% | +40.0% |
| Q3 2022 | $2,040,000 | -33.4% | 472,351 | +36.7% | 0.01% | -28.6% |
| Q2 2022 | $3,064,000 | -4.6% | 345,550 | +42.7% | 0.01% | 0.0% |
| Q1 2022 | $3,213,000 | +6.2% | 242,220 | +104.4% | 0.01% | 0.0% |
| Q4 2021 | $3,026,000 | -0.7% | 118,525 | +12.6% | 0.01% | 0.0% |
| Q3 2021 | $3,048,000 | -17.7% | 105,300 | +3.4% | 0.01% | -22.2% |
| Q2 2021 | $3,704,000 | -13.6% | 101,800 | +17.7% | 0.01% | -18.2% |
| Q1 2021 | $4,289,000 | -9.6% | 86,525 | +3.1% | 0.01% | -15.4% |
| Q4 2020 | $4,743,000 | +3.1% | 83,900 | +1.0% | 0.01% | +550.0% |
| Q3 2020 | $4,602,000 | +45.2% | 83,050 | +1.2% | 0.00% | 0.0% |
| Q2 2020 | $3,169,000 | +1525.1% | 82,050 | +71.8% | 0.00% | – |
| Q1 2020 | $195,000 | – | 47,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,430,270 | $10,134,226 | 3.30% |
| Westside Investment Management, Inc. | 528,310 | $2,203,060 | 0.63% |
| Acuitas Investments, LLC | 219,000 | $913,230 | 0.54% |
| EAM Investors, LLC | 256,623 | $1,070,118 | 0.21% |
| Parkman Healthcare Partners LLC | 165,000 | $688,050 | 0.13% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 110,016 | $458,767 | 0.08% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 300,000 | $1,251,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 271,462 | $1,131,997 | 0.03% |
| Quantum Private Wealth, LLC | 11,500 | $47,955 | 0.02% |
| CHICAGO TRUST Co NA | 16,700 | $69,639 | 0.02% |